Ozempic vs Wegovy
Same active ingredient, different FDA approvals and dosing
Ozempic
GLP-1 receptor agonistWegovy
GLP-1 receptor agonistHow They Work
Ozempic
GLP-1 receptor agonist. Identical active ingredient to Wegovy at a lower max dose.
Wegovy
Identical to Ozempic (semaglutide) but dosed higher and approved specifically for weight loss.
Weight Loss Efficacy
SUSTAIN trials focused on A1C reduction in type 2 diabetes, with weight loss as secondary outcome
STEP 1 trial: 14.9% body weight loss at 2.4 mg vs 2.4% with placebo (68 weeks, n=1,961)
Side Effects
Ozempic
- Nausea (20%)
- Diarrhea (9%)
- Vomiting (10%)
- Constipation (5%)
- Abdominal pain (6%)
Wegovy
- Nausea (44%)
- Diarrhea (30%)
- Vomiting (24%)
- Constipation (24%)
- Abdominal pain (20%)
Cost Comparison
| Ozempic | Wegovy | |
|---|---|---|
| Without Insurance | $900-$1,000/month | $1,300-$1,400/month |
| With Insurance | $0-$25/month for diabetes indication | $0-$25/month with qualifying commercial plans |
| Compounded | Compounded semaglutide: $200-$500/month | Compounded semaglutide: $200-$500/month |
Pros & Cons
Ozempic
Advantages
- Strong insurance coverage for type 2 diabetes
- Well-established 7+ year safety record
- Same active ingredient as Wegovy
- Lower starting cost
Considerations
- Not FDA-approved for weight loss
- Max dose 2 mg (vs 2.4 mg for Wegovy)
- Off-label weight loss use may not be covered by insurance
- Prescribing requires a diabetes or related diagnosis for coverage
Wegovy
Advantages
- FDA-approved specifically for weight loss
- Higher max dose (2.4 mg) for greater efficacy
- Growing insurance coverage for weight management
- Cardiovascular risk reduction benefit (SELECT trial)
Considerations
- Higher list price than Ozempic
- More frequent/intense side effects at higher doses
- Insurance coverage less universal than Ozempic for diabetes
- Supply constraints have occurred historically
The Bottom Line
Ozempic and Wegovy contain the same drug (semaglutide) but are FDA-approved for different conditions. If you have type 2 diabetes, Ozempic likely offers better insurance coverage. If your primary goal is weight loss and you don't have diabetes, Wegovy is the appropriate prescription with a higher max dose (2.4 mg vs 2 mg) and clinical data specifically supporting weight management.
Frequently Asked Questions
Essentially, yes. Both are semaglutide made by Novo Nordisk. Wegovy goes up to 2.4 mg/week and is FDA-approved for weight loss. Ozempic caps at 2 mg/week and is FDA-approved for type 2 diabetes. The formulations and auto-injector pens differ slightly.
Common reasons include insurance coverage (Ozempic may be covered when Wegovy isn't), supply availability, or if you also have diabetes or prediabetes. Off-label prescribing of Ozempic for weight loss is common clinical practice.
The side effects are similar since both are semaglutide, but Wegovy's higher dose (2.4 mg) is associated with more frequent GI side effects in clinical trials. The gradual dose escalation helps minimize this.
Yes, with your doctor's guidance. Since both are semaglutide, switching is straightforward. Your doctor will match or adjust the dose based on your current level and treatment goals.
Medical Disclaimer: This comparison is for informational purposes only and is not medical advice. All clinical data is sourced from FDA prescribing information and published peer-reviewed trials. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or switching any medication.